Evidence map›Paper›PMID 37889232›Full record

ArticleBrazilian journal of cardiovascular surgery2023

Extracorporeal Membrane Oxygenation Uses in Refractory Cardiogenic Shock After Open-Heart Surgery.

Pablo Salazar Elizalde, German J Chaud, Joaquín Gundelach, Barbara Gaete, Marcos Durand, Ignacio Cuadra, Sinthya Provoste, Enrique Yanten, Marcelo Tiznado, Cristóbal Alvarado

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brazilian journal of cardiovascular surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Pablo Salazar ElizaldeCardiac Surgery Department and ECMO Unit, Las Higueras Hospital, Talcahuano, Chile.
German J ChaudCardiac Surgery Department and ECMO Unit, Las Higueras Hospital, Talcahuano, Chile.
Joaquín GundelachCardiac Surgery Department and ECMO Unit, Las Higueras Hospital, Talcahuano, Chile.
Barbara GaeteCardiac Surgery Department and ECMO Unit, Las Higueras Hospital, Talcahuano, Chile.
Marcos DurandCardiac Surgery Department and ECMO Unit, Las Higueras Hospital, Talcahuano, Chile.
Ignacio CuadraCardiac Surgery Department and ECMO Unit, Las Higueras Hospital, Talcahuano, Chile.
Sinthya ProvosteCardiac Surgery Department and ECMO Unit, Las Higueras Hospital, Talcahuano, Chile.
Enrique YantenCardiac Surgery Department and ECMO Unit, Las Higueras Hospital, Talcahuano, Chile.
Marcelo TiznadoCardiac Surgery Department and ECMO Unit, Las Higueras Hospital, Talcahuano, Chile.
Cristóbal AlvaradoBiomedical Research Unit, Las Higueras Hospital, Talcahuano, Chile.
Hospital Las Higueras · CLUniversidad Católica de la Santísima Concepción · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionExtracorporeal membrane oxygenation (ECMO) is the first-line therapy for temporary mechanical circulatory support allowing cardiac and pulmonary recovery or as a bridge to further therapeutic alternatives. The aim of this study was to report clinical outcomes in adult patients with refractory cardiac failure after open-heart surgery undergoing ECMO in a single center with an ECMO unit in Chile.

methodsWe retrospectively analyzed adults with refractory cardiac failure after open-heart surgery who required a venoarterial (VA) ECMO between 2016 and 2021.

resultsOf 16 patients with VA ECMO, 60% were men (n=10), 90% had hypertension (n=14), 69% had < 30% of left ventricular ejection fraction (n=11), and the mean European System for Cardiac Operative Risk Evaluation II score was 12 ± 11%. ECMO support with central cannulation accounts for 81% (n=13), and an intra-aortic balloon pump was used in nine patients (56%). The mean time of support was 4.7 ± 2.6 days (1.5 - 12 days). ECMO weaning was achieved in 88% of patients, and in-hospital mortality was 44% (n=7) after discharge. The freedom from all-cause mortality at one year of follow-up of the entire cohort was 38% (n=6).

conclusionVA ECMO is now a well-known life-saving therapeutic option, but mortality and morbidity remain high. Implementation of an ECMO program with educational training is mandatory in order to find the proper balance between patient benefits, ethical considerations, and public health financial input in South America.

Indexed as

Cardiac Surgical ProceduresExtracorporeal Membrane OxygenationHeart FailureAdultFemaleHumansMaleRetrospective StudiesShock, CardiogenicStroke VolumeVentricular Function, LeftCatheterizationExtracorporeal Membrane OxygenationHeart FailureLeft Ventricular FunctionMorbidityStroke Volume

Identifiers

PMID37889232
PMCPMC10611424
OpenAlexW4387966603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.